Clinical Trial: A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863635) titled 'A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations' on Oct. 02.

Brief Summary: The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1283 and mRNA-1273 (variant formulations) within the current epidemiological environment

Study Start Date: Oct. 09

Study Type: INTERVENTIONAL

Condition: SARS-CoV-2

Intervention: BIOLOGICAL: mRNA-1273

Sterile liquid for injection

BIOLOGICAL: mRNA-1283

Sterile liquid for injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ModernaTX, Inc.

Published by HT Digital Content Services with permission from Health Daily D...